Dr. rer. nat. Gerald Burgstaller
Group Leader Immunotherapeutic Technologies"My vision is to discover and develop innovative therapeutics tackling chronic lung diseases and identify novel molecular targets as well as elucidating the mode-of-action. This only can be achieved by highly multi- and interdisciplinary work and thriving academic, clinical and industrial collaborations."
My vision is to discover and develop innovative therapeutics tackling chronic lung diseases and identify novel molecular targets as well as elucidating the mode-of-action. This only can be achieved by highly multi- and interdisciplinary work and thriving academic, clinical and industrial collaborations.
Skills
Chronic Lung Diseases Cell Biology Extracellular MatrixDrug Discovery Human Lung Disease Models Advanced Microscopy
Professional Background
Principal Investigator/Research group leader at Helmholtz Munich, Institute of Lung Health and Immunity, Comprehensive Pneumology Center (CPC)
Staff Scientist at Helmholtz Munich, Head of Imaging Core Facility, Institute of Lung Biology and Disease, Comprehensive Pneumology Center (CPC)
Postdoc at Helmholtz Munich, Head of Imaging Core Facility, Institute of Lung Biology and Disease, Comprehensive Pneumology Center (CPC)
Postdoc at Helmholtz Munich, Institute of Clinical Molecular Biology and Tumor Genetics
Postdoc at Max Perutz Laboratories Vienna, Austria
Doctorial researcher at Austrian Academy of Sciences in Salzburg, Austria
Publications
Read more2024 Scientific Article in Nature Communications
LungVis 1.0: An automatic AI-powered 3D imaging ecosystem unveils spatial profiling of nanoparticle delivery and acinar migration of lung macrophages.
2024 Scientific Article in JCI insight
Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis.
2024 Scientific Article in Thorax
COPD basal cells are primed towards secretory to multiciliated cell imbalance driving increased resilience to environmental stressors.
2024 Scientific Article in European Respiratory Journal
Sfrp1 inhibits lung fibroblast invasion during transition to injury induced myofibroblasts.
2023 Scientific Article in Science Translational Medicine
Ex vivo tissue perturbations coupled to single-cell RNA-seq reveal multilineage cell circuit dynamics in human lung fibrogenesis.
2023 Scientific Article in OpenNano